Microbot Medical Inc.
MBOT · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $10 | $12 | $0 | $26 |
| Gross Profit | -$10 | -$12 | $0 | -$26 |
| % Margin | – | – | – | – |
| R&D Expenses | $1,161 | $2,099 | $1,459 | $1,958 |
| G&A Expenses | $0 | $1,612 | $1,562 | $0 |
| SG&A Expenses | $2,690 | $1,612 | $1,562 | $1,446 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,851 | $3,711 | $3,021 | $3,404 |
| Operating Income | -$3,861 | -$3,723 | -$3,021 | -$3,430 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $284 | $223 | $420 | $38 |
| Pre-Tax Income | -$3,577 | -$3,500 | -$2,601 | -$3,392 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,577 | -$3,500 | -$2,601 | -$3,392 |
| % Margin | – | – | – | – |
| EPS | -0.074 | -0.096 | 0.006 | -0.2 |
| % Growth | 22.4% | -1,672.1% | 103.1% | – |
| EPS Diluted | -0.074 | -0.096 | 0.006 | -0.2 |
| Weighted Avg Shares Out | 48,095 | 36,488 | 17,019 | 17,019 |
| Weighted Avg Shares Out Dil | 48,095 | 36,488 | 17,019 | 17,019 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $223 | $104 | $38 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $10 | $12 | $15 | $26 |
| EBITDA | -$3,567 | -$3,488 | -$3,006 | -$3,366 |
| % Margin | – | – | – | – |